Status:
COMPLETED
Oral Administration of Colostrum to Premature Babies: Impact on the Oral Microbiota
Lead Sponsor:
University of California, Davis
Conditions:
Changes in the Oral Microbiota
Eligibility:
All Genders
12-7 years
Phase:
NA
Brief Summary
Oropharyngeal administration of mother's colostrum to premature infants has been proposed as a stimulus to the oropharyngeal lymphatic tissues to decrease the incidence of pneumonia and sepsis, partic...
Eligibility Criteria
Inclusion
- premature infant with birth weight \< 1500
- intubated in the first 48 hours of life
- available maternal colostrum
Exclusion
- lethal condition
Key Trial Info
Start Date :
October 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2016
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT02306980
Start Date
October 1 2013
End Date
June 1 2016
Last Update
July 25 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UC Davis Children's Hospital
Sacramento, California, United States, 95817